Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Tumor Reactive T Cells Drive Clinical Responses to Multiple Myeloma

Tim Robin Wagner, Niklas Kehl, Simon Steiger, Tamara Boschert, Michael Kilian, Kane A Foster, Hartmut Goldschmidt, Niels Weinhold, Steven A. Carr, Kwee Yong, Carsten Müller-Tidow, Karsten Rippe, Marc S. Raab, Michael Platten, Stefan B Eichmüller, Mirco Julian Friedrich

Blood (2024) 144 (Supplement 1): 1890.

https://doi.org/10.1182/blood-2024-210272

Published: 2024

Journal Articles

Tumour-Intrinsic Features Shape T-Cell Differentiation through Myeloma Disease Evolution

Blood (2024) 144 (Supplement 1): 669.

https://doi.org/10.1182/blood-2024-203306

Published: 2024

Journal Articles

A Paradoxal Reaction from Intravenous Immunoglobulin

Dawson A Foster, Endurance O Evbayekha, Joseph Sokhn

Blood (2023) 142 (Supplement 1): 5572.

https://doi.org/10.1182/blood-2023-174702

Published: 2023

Journal Articles

A Shared SF3B1 Neoantigen Is Presented on Primary Malignant Cells and Induced Pluripotent Stem Cell-Derived Hematopoietic Lines

Melinda Ann Biernacki, Kimberly A Foster, Courtnee Clough, Stephanie Busch, B.S., Carrie Cummings, Vivian G. Oehler, MD, Derek Stirewalt, MD, Sergei Doulatov, PhD, Marie Bleakley, MBBS MMSc PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-139907

Published: 2020

Journal Articles

Final Results and Follow-up of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (aka MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Jennifer A. Woyach, MD, Farrukh Awan, MD MS, Ian Flinn, Jesus G. Berdeja, MD, Elizabeth A Wiley, Sharmeen Mansoor, Ying Huang, MA, MS, Gerard Lozanski, MD, Paul A. Foster, MD, John C. Byrd, MD

Blood (2014) 124 (21): 1993.

https://doi.org/10.1182/blood.V124.21.1993.1993

Published: 2014

Journal Articles

A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL

Jennifer A. Woyach, Farrukh Awan, Ian W. Flinn, Jesus G. Berdeja, Elizabeth Wiley, Sharmeen Mansoor, Ying Huang, Gerard Lozanski, Paul A. Foster, John C. Byrd

Blood (2014) 124 (24): 3553–3560.

https://doi.org/10.1182/blood-2014-08-593269

Published: 2014

Includes: Supplemental data

Journal Articles

Final Results of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

Jennifer A. Woyach, MD, Farrukh Awan, MD, MS, Ian W. Flinn, MD, PhD, Rolondo Enoch, MS, Paul A. Foster, MD, John C. Byrd, MD

Blood (2012) 120 (21): 2894.

https://doi.org/10.1182/blood.V120.21.2894.2894

Published: 2012

Journal Articles

Transgenic Expression of Inducible Caspase9 Suicide Gene for In Vivo Elimination of Antigen Specific Cytotoxic T Cells (CTLs) Engineered To Produce Cytokines.

C. Quintarelli, PhD, V. Juan, MD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen M. Heslop, MD, C. Rooney, PhD, Malcolm K. Brenner, MD, PhD, G. Dotti, MD

Blood (2006) 108 (11): 137.

https://doi.org/10.1182/blood.V108.11.137.137

Published: 2006

Journal Articles

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

J. Vera, MD, C. Quintarelli, PhD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen Heslop, MD, C. Rooney, PhD, Malcolm Brenner, MD, PhD, G. Dotti, MD

Blood (2006) 108 (11): 1721.

https://doi.org/10.1182/blood.V108.11.1721.1721

Published: 2006

Journal Articles

Improved Homing of Antigen-Specific T Cells to Hodgkin’s Disease (HD) Tumor Cells by Forced Expression of CCR4 Receptor.

A. Di Stasi, MD, G. Dotti, MD, A. Foster, PhD, L. Zhang, Helen H. Heslop, MD, C. Rooney, PhD, Malcolm K. Brenner, MD, B. Savoldo, MD

Blood (2006) 108 (11): 472.

https://doi.org/10.1182/blood.V108.11.472.472

Published: 2006

Journal Articles

Comparison of Umbilical Cord Collection Methods: Impact on Cellularity and Microbial Contamination Rates.

Karen A. Foster, MSc, MBA, Scott Chasan-Taber, Ph.D, Robert A. Dracker, MD, Kurt C. Gunter, MD

Blood (2005) 106 (11): 5279.

https://doi.org/10.1182/blood.V106.11.5279.5279

Published: 2005

Journal Articles

Incidence of Altered Biodistribution Detected by Indium 111 ( 111 In) Imaging Prior to Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy: Results from a Zevalin Imaging Registry.

Peter Conti, MD, Christine White, MD, Peter Pieslor, MD, Gene Menendez, V. Douglas Harrough, MS, MBA, Dan Matso, PharmD, Jacqueline Aussie, Thomas Ryskamp, Paul A. Foster, MD

Blood (2004) 104 (11): 4570.

https://doi.org/10.1182/blood.V104.11.4570.4570

Published: 2004

Journal Articles

Importance of Transplantation Variables in Marrow to Muscle Conversion.

Mehrdad Abedi, MD, Deborah A. Greer, Bethany A. Foster, Gerald A. Colvin, DO, Jashua A. Harpel, Mark S. Dooner, Peter J. Quesenberry, MD

Blood (2004) 104 (11): 2691.

https://doi.org/10.1182/blood.V104.11.2691.2691

Published: 2004

Journal Articles

Marrow Derived Muscle Colonies Are a Clonal Phenomenon.

Mehrdad Abedi, MD, Deborah A. Greer, Bethany A. Foster, Delia A. Demers, Gerald A. Colvin, DO, Mark S. Dooner, Peter J. Quesenberry, MD

Blood (2004) 104 (11): 2692.

https://doi.org/10.1182/blood.V104.11.2692.2692

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tumor Reactive T Cells Drive Clinical Responses to Multiple Myeloma

Tumour-Intrinsic Features Shape T-Cell Differentiation through Myeloma Disease Evolution

A Paradoxal Reaction from Intravenous Immunoglobulin

A Shared SF3B1 Neoantigen Is Presented on Primary Malignant Cells and Induced Pluripotent Stem Cell-Derived Hematopoietic Lines

Final Results and Follow-up of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (aka MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL

Final Results of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

Transgenic Expression of Inducible Caspase9 Suicide Gene for In Vivo Elimination of Antigen Specific Cytotoxic T Cells (CTLs) Engineered To Produce Cytokines.

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

Improved Homing of Antigen-Specific T Cells to Hodgkin’s Disease (HD) Tumor Cells by Forced Expression of CCR4 Receptor.

Comparison of Umbilical Cord Collection Methods: Impact on Cellularity and Microbial Contamination Rates.

Incidence of Altered Biodistribution Detected by Indium 111 ( 111 In) Imaging Prior to Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy: Results from a Zevalin Imaging Registry.

Importance of Transplantation Variables in Marrow to Muscle Conversion.

Marrow Derived Muscle Colonies Are a Clonal Phenomenon.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only